4.1. Socio-Demographic Characteristics
The mean age differed significantly (p < 0.001). Novara’s patients were younger (42.5 ± 18.29 years) compared to Alessandria’s (47.1 ± 17.07 years). The 18–34 age group was significantly more represented in Novara (41.6%) compared to Alessandria (27.3%). Gender distribution was similar (47.43% male, 52.57% female; p = 0.986).
Self-referral was significantly higher in Alessandria (58.40%) compared to Novara (34.68%; p < 0.001). Novara recorded a greater incidence of referrals from General Practitioners (GPs)/118 (25.05%) and specialist psychiatric physicians/SerD (12.52%). Novara patients were also more frequently single/celibate (63.76% vs. 47.85%; p < 0.001). Alessandria showed a higher proportion of married/cohabiting individuals (36.36% vs. 27.75%) and pensioners (21.95% vs. 10.39%) (Table 1).
4.2. Clinical Precedents and Pathology
Novara reported significantly higher rates of previous psychiatric history (76.25% vs. 57.30%), prior psychiatric hospitalisations (49.81% vs. 36.62%), formal psychiatric diagnoses (78.25% vs. 61.85%), and current psychopharmacological therapy (71.38% vs. 55.71%) (p < 0.001 for all comparisons). This pattern suggests a Novara population with greater clinical complexity and chronicity (Zimmerman et al., 2018; Di Lorenzo et al., 2020) (Table 2).
Alessandria showed higher rates of current (10.26% vs. 5.08%) and previous SerD follow-up (17.49% vs. 7.69%; p < 0.001).
Regarding psychiatric diagnoses, Novara showed a higher prevalence of Personality Disorders (26.60% vs. 21.57%) and Schizophrenia spectrum disorders (23.99% vs. 17.26%). Alessandria showed higher percentages of Depressive disorders (20.30% vs. 8.08%), Bipolar disorders (11.42% vs. 5.94%), and Anxiety disorders.
In terms of pharmacotherapy, Novara showed a greater use of typical oral neuroleptics (22.92% vs. 10.54%), atypical oral neuroleptics (36.98% vs. 27.64%), benzodiazepines (68.75% vs. 58.69%), and Long-Acting Injectable (LAI) formulations (typical 8.59% vs. 3.70%; atypical 6.25% vs. 3.99%). Alessandria reported higher prescriptions of mood stabilisers (29.06% vs. 14.32%) and anticonvulsants (10.54% vs. 7.03%).
4.3. Symptomatology
The distribution of main symptoms differed highly significantly between the centres (p < 0.001). Novara reported higher rates of anxious state (34.62% vs. 30.66%), psychomotor agitation (20.07% vs. 14.64%), psychotic symptomatology (11.97% vs. 9.86%), and cognitive alterations (2.95% vs. 0.77%). Alessandria showed a higher frequency of mood alterations (15.10% vs. 7.92%), intoxications (11.86% vs. 6.45%), and cases with a negative psychiatric objective exam (12.33% vs. 7.18%) (Table 3).
4.4. Dependencies
Novara reported a higher prevalence of dependence diagnoses (27.26% vs. 22.22%; p = 0.048). Conversely, elevated blood alcohol levels (>0.5 ng/ml) were slightly more frequent in Alessandria (13.31% vs. 9.42%; p = 0.050).
Crucially, Novara had a significantly higher percentage of positive screens for other substances (excluding alcohol) (67.84% vs. 12.22%; p < 0.001). This disparity is likely due to methodological differences in toxicological screening protocols. The most frequently reported dependency diagnoses overall were alcohol (51.24%), cannabis (36.4%), and stimulants (29.3%) (Table 4).
4.5. Suicidal Behaviours
Novara displayed a higher incidence of suicidal ideation (19.89% vs. 12.42%) and self-harming acts (20.60% vs. 10.16%) (p < 0.001). Conversely, the will to self-preserve (conscious suicidal intent) was significantly higher in Alessandria (39.68% vs. 23.36%; p = 0.024). Short-circuit behaviours (impulsive acts) were similarly distributed (p = 0.509).
The most frequent self-harm modality overall was voluntary ingestion (56.7%). Alessandria reported higher rates of potentially lethal acts such as hanging (13.1%) and defenestration (8.2%) (Table 5).
4.5.1. Age and Gender Associations (Multivariate Analysis)
Multivariate logistic regression confirmed a significant association between female sex and self-harming behaviours (OR = 1.57; CI 95%: 1.13–2.19; p = 0.008). This indicates women had an approximately 1.6 times increased probability of self-harming acts compared to men. Other outcomes, including suicide, conscious intent, and acute presentation, did not show statistically significant associations with female sex (Table 6).
Analysis of mean age revealed that subjects with reported suicide, self-harm, and acute presentation were significantly younger (p-value = 0.0002). However, the group exhibiting the will to self-preserve (fatal intent) was considerably older (45.39 years) than those without this intent (36.01 years; p = 0.0014) (Table 7).
4.6. Acute Therapy
Novara administered acute therapy significantly more often (51.13%) than Alessandria (39.59%; p < 0.001). This is correlated with Novara's higher prevalence of psychomotor agitation and anxiety. The most common acute pharmacological intervention overall was parenteral benzodiazepine administration (50.1%) (Table 8).
4.7. Outcome
Intervention outcomes differed significantly (p < 0.001). Novara registered a higher prevalence of compulsory hospitalisations (TSO) (7.04% vs. 3.08%) and voluntary hospitalisations (40.74% vs. 25.85%). This suggests a more intensive, hospital-oriented approach in Novara. Alessandria utilised territorial services more, with higher discharge rates (27.23% vs. 18.89%) and referral rates to Community Mental Health Centres (CMHC) (21.23% vs. 17.96%) (Table 9).